Oscar Health (OSCR) Set to Announce Quarterly Earnings on Thursday

Oscar Health (NYSE:OSCR) will likely be releasing its Q3 2026 results before the market opens on Thursday, November 5th. Analysts expect the company to announce earnings of ($0.1438) per share and revenue of $4.69 billion for the quarter. Interested persons can find conference call details on the company’s upcoming Q3 2026 earnings summary page for the latest details on the call scheduled for Thursday, November 5, 2026 at 8:00 AM ET.

Oscar Health (NYSE:OSCR) last posted its earnings results on Thursday, August 6th. The company reported $1.10 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.40 by $0.70. The firm had revenue of $4.88 billion during the quarter, compared to analysts’ expectations of $4.73 billion. Oscar Health had a net margin of 3.60% and a return on equity of 38.45%. The company’s revenue was up 70.4% compared to the same quarter last year. During the same period in the previous year, the company earned ($0.89) earnings per share. On average, analysts expect Oscar Health to post $1.83 EPS for the current fiscal year and $2.22 EPS for the next fiscal year.

Oscar Health Stock Performance

OSCR stock opened at $32.38 on Wednesday. The company has a market capitalization of $9.99 billion, a price-to-earnings ratio of 23.13, a P/E/G ratio of 0.34 and a beta of 2.56. The firm has a 50 day moving average of $31.68 and a two-hundred day moving average of $23.72. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 0.21. Oscar Health has a 12 month low of $10.69 and a 12 month high of $35.01.

Insider Activity

In related news, Director Mario Schlosser sold 600,000 shares of the company’s stock in a transaction on Thursday, August 27th. The shares were sold at an average price of $30.34, for a total transaction of $18,204,000.00. Following the completion of the transaction, the director directly owned 480,866 shares in the company, valued at $14,589,474.44. This represents a 55.51% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Vanessa Wittman sold 25,000 shares of the stock in a transaction on Friday, September 18th. The shares were sold at an average price of $32.24, for a total transaction of $806,000.00. Following the completion of the sale, the director directly owned 112,121 shares of the company’s stock, valued at approximately $3,614,781.04. This trade represents a 18.23% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 874,451 shares of company stock worth $26,761,671. Corporate insiders own 22.64% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on OSCR. Bank of America upped their price objective on shares of Oscar Health from $28.00 to $30.00 and gave the stock an “underperform” rating in a report on Thursday, September 17th. Barclays raised their target price on Oscar Health from $39.00 to $49.00 and gave the company an “overweight” rating in a report on Thursday, September 17th. Piper Sandler reaffirmed an “overweight” rating and issued a $48.00 price target on shares of Oscar Health in a research report on Thursday, September 17th. Wells Fargo & Company boosted their price target on Oscar Health from $20.00 to $27.00 and gave the stock an “equal weight” rating in a research report on Thursday, August 13th. Finally, The Goldman Sachs Group reiterated a “neutral” rating and set a $34.00 price target on shares of Oscar Health in a research note on Thursday, September 17th. One analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $34.90.

Oscar Health Company Profile

Oscar Health, Inc is a technology-focused health insurance company that provides health plans and related services in the United States. The company primarily serves individuals and families purchasing coverage through the Affordable Care Act’s health insurance marketplace, as well as small businesses and their employees.

Oscar combines health insurance products with digital tools designed to help members manage their care. Its services include online enrollment, virtual care, provider search and appointment support, care navigation, claims and benefits information, and member engagement through web and mobile applications.